Lyndra Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
65 Grove St, Watertown, Massachusetts, 0...Phone Number
(857) 304-4512Website
www.lyndra.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Lyndra Therapeutics
Lyndra Therapeutics, founded in 2015 and headquartered in Watertown, Massachusetts, is a pharmaceutical manufacturing company.Explore more
Lyndra Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lyndra Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lyndra Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Lyndra Therapeutics
Product Launch: Get notified when Lyndra Therapeutics launches new products
Click to see if Lyndra Therapeutics had a recent Job posting/layoffs
Check if Lyndra Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Lyndra Therapeutics is spiking on competitors!
Lyndra Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Lyndra Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Lyndra Therapeutics
Find more new buyers
Compare Similar Companies to Lyndra Therapeutics
Compare insights from companies similar to Lyndra Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lyndra Therapeutics
$5.2M
51-200
Private
$239.5M
2015
TB
Thomas BrussardVice President, Financial Planning & Analysis
Company Profile Activity
Activity Insights
Lyndra Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lyndra Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lyndra Therapeutics.
Lyndra Therapeutics financials insights
Gather financial insights about Lyndra Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$23M
2019
Series B
$55M
2021
Series C
$60.5M
2023
Series E
$101M
Lyndra Therapeutics Tech Stack
A closer look at the technologies used by Lyndra Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Person-Based
Person-Based
Lyndra Therapeutics News & Media
Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the Board of Directors has appointed Adam Sayer as President and Chief Executive Officer effective immediately. He will also serve on the company’s Board of Directors. Sayer was most recently Chief Transformation Officer at Envision Healthcare, overseeing strategy, transformation and payer negotiations. His deep understanding of the healthcarLyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, in which Thermo Fisher will provide global clinical research and commercial manufacturing services to Lyndra for its long-acting oral therapies. Lyndra’s long-acting oral therapies, including lead investigational product oral weekly risperidone (Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study Demonstrating Efficacy of Oral Weekly Risperidone Compared to Daily RisperdalLyndra Therapeutics Raises $101 Million in Series E Funding
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics closed a $101 million Series E financing round led by Sarissa Capital and including Sun Pharma and Polaris Partners.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lyndra Therapeutics
Sign Up For FreeTo access detailed company insights
Lyndra Therapeutics, founded in 2015 and headquartered in Watertown, Massachusetts, is a pharmaceutical manufacturing company.... Read More
